Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making

Ítems similars

• Prognostic validation and therapeutic decision‐making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy
  per: San‐Gang Wu, et al.
  Publicat: (2020-03-01)
• Prognostic validation and therapeutic decision‐making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy
  per: Wu, San‐Gang, et al.
  Publicat: (2020)
• AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer
  per: He, Jiehua, et al.
  Publicat: (2020)
• Prognostic validation and treatment decision making of the 8(th) edition of the American Joint Committee on Cancer pathological staging system for elderly women with early-stage breast cancer
  per: Wu, San-Gang, et al.
  Publicat: (2020)
• The prognostic and predictive value of the 8th American Joint Committee on Cancer (AJCC) staging system among early breast cancer patients aged <50 years
  per: Wang, Jun, et al.
  Publicat: (2021)